These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11012184)

  • 1. The effect of MGDF on platelet function and thrombosis in animal models.
    Toombs CF
    Stem Cells; 1998; 16 Suppl 2():121-6. PubMed ID: 11012184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and Thrombosis.
    Lott FA; Nelson AG; Toombs CF
    J Thromb Thrombolysis; 1998; 5(1):15-23. PubMed ID: 10608045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
    Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
    Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J
    Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
    Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
    Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
    Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P
    Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prothrombotic effects of pegylated recombinant human megakaryocyte growth and development factor in thrombocytopenic state in a rat thrombosis model.
    Nishiyama U; Kuwaki T; Akahori H; Kato T; Ikeda Y; Miyazaki H
    J Thromb Haemost; 2005 Feb; 3(2):355-60. PubMed ID: 15670044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets in thrombotic disorders: quantitative and qualitative platelet disorders predisposing to arterial thrombosis.
    Harker LA
    Semin Hematol; 1998 Jul; 35(3):241-52. PubMed ID: 9685170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human megakaryocyte growth and development factor coupled with polyethylene glycol on the platelet storage lesion.
    Snyder E; Perrotta P; Rinder H; Baril L; Nichol J; Gilligan D
    Transfusion; 1999 Mar; 39(3):258-64. PubMed ID: 10204587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice.
    Shibuya K; Kuwaki T; Akahori H; Kato T; Miyazaki H
    Leuk Res; 2004 Sep; 28(9):941-6. PubMed ID: 15234571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
    Catani L; Gugliotta L; Motta M; Tazzari P; Baravelli S; Tura S
    Haematologica; 1998 May; 83(5):385-91. PubMed ID: 9658720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
    Neumann TA; Foote M
    Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
    Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
    Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG
    Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.
    Geissler K; Yin JA; Ganser A; Sanz MA; Szer J; Raghavachar A; Hoelzer D; Martinez C; Taylor K; Kanz L; To LB; Archimbaud E
    Ann Hematol; 2003 Nov; 82(11):677-83. PubMed ID: 14530872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.